First Citizens BancShares Inc vs Pfizer Inc — how do they compare? First Citizens BancShares Inc trades at $2,124.52 (market cap $23.76B), while Pfizer Inc trades at $25.25 (market cap $141.46B). The key difference: Pfizer Inc is far larger — about 6× First Citizens BancShares Inc's market cap, and Pfizer Inc pays the higher dividend (6.93%). Which is the better fit depends on your goals.
| FCNCA | PFE | |
|---|---|---|
Market Cap | $23.76B | $141.46B |
Sector | Sector/Thematic | Health |
52-Week High | $2.20K | $28.56 |
52-Week Low | $1.64K | $23.29 |
Dividend Yield | 0.41% | 6.93% |
Volume | — | 29,869,932 |
Enterprise Value | — | $192.12B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Pfizer (PFE) trades at $24.25, down 0.94% on the day, with a bearish technical signal from moving averages. The company reported $62.58B in 2025 revenue and a net income margin of 11.83%, with recent quarterly earnings consistently beating expectations. A dividend of $0.43 per share is scheduled for payment on September 1, 2026. The stock's valuation includes a P/E of 18.51 and P/S of 2.19, while analyst consensus price target is $28.25.
Pfizer presents a mixed outlook with stable profitability and a strong dividend, but faces headwinds from patent expirations and competitive pressures. The stock offers value at current levels relative to analyst targets, though technical weakness and revenue declines from peak COVID-era sales pose near-term risks for investors.
Trailing returns across standard periods
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →